Aureum Diagnostics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.54M

  • Investors
  • 3

Aureum Diagnostics General Information

Description

Developer of a diagnosis and testing tool designed to diagnose COVID and other life-threatening conditions. The company's electrochemical sensor and handheld low-cost instrument platform combine proprietary sensors, reagents, and instrumentation innovations, enabling clinicians to get a rapid and extremely sensitive measurement of multiple biologically important targets.

Contact Information

Website
aureumdx.co.uk
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Second Floor, Suite 1
  • Maxim 1, 2 Parklands Way Maxim Park Eurocentral
  • Glasgow ML1 4WR
  • Scotland, United Kingdom
+44 07494
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • Second Floor, Suite 1
  • Maxim 1, 2 Parklands Way Maxim Park Eurocentral
  • Glasgow ML1 4WR
  • Scotland, United Kingdom
+44 07494

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aureum Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 12-May-2022 $1.54M Completed Generating Revenue
1. University Spin-Out 15-Feb-2021 Completed Startup
To view Aureum Diagnostics’s complete valuation and funding history, request access »

Aureum Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
Ordinary A1
Ordinary A1 289,280 $0.012688 $3.39 $3.39 1x $3.39 5.44%
To view Aureum Diagnostics’s complete cap table history, request access »

Aureum Diagnostics Patents

Aureum Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202415468-D0 Methods and fuel cell devices for detecting analytes Pending 21-Oct-2024
WO-2026087880-A1 Methods and fuel cell devices for detecting analytes Pending 21-Oct-2024
GB-202415467-D0 Test strip Pending 21-Oct-2024
WO-2026087882-A1 Test strip Pending 21-Oct-2024
EP-4795191-A1 Methods and systems for electrochemical detection Pending 19-Oct-2023 C12Q1/005
To view Aureum Diagnostics’s complete patent history, request access »

Aureum Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aureum Diagnostics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innova Partnerships Venture Capital Minority
Norcliffe Capital Venture Capital Minority
The University of Strathclyde University Minority
To view Aureum Diagnostics’s complete investors history, request access »

Aureum Diagnostics FAQs

  • When was Aureum Diagnostics founded?

    Aureum Diagnostics was founded in 2021.

  • Where is Aureum Diagnostics headquartered?

    Aureum Diagnostics is headquartered in Glasgow, United Kingdom.

  • What is the size of Aureum Diagnostics?

    Aureum Diagnostics has 11 total employees.

  • What industry is Aureum Diagnostics in?

    Aureum Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Aureum Diagnostics a private or public company?

    Aureum Diagnostics is a Private company.

  • What is the current valuation of Aureum Diagnostics?

    The current valuation of Aureum Diagnostics is .

  • What is Aureum Diagnostics’s current revenue?

    The current revenue for Aureum Diagnostics is .

  • How much funding has Aureum Diagnostics raised over time?

    Aureum Diagnostics has raised $1.54M.

  • Who are Aureum Diagnostics’s investors?

    Innova Partnerships, Norcliffe Capital, and The University of Strathclyde have invested in Aureum Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process